Academician Ma Jun
CAS Academician · Professor · Chief Physician
Academic Profile
Academician Ma Jun is the leading figure in nasopharyngeal carcinoma (NPC) care in China, serving as Executive Deputy Director of Sun Yat-sen University Cancer Center and chief expert of its NPC MDT team. His study series have repeatedly rewritten international NPC guidelines.
His studies established induction chemotherapy plus concurrent chemoradiotherapy as the standard of care, and brought immunotherapy and metronomic chemotherapy into full-course NPC management — improving survival while reducing toxicity.
Appointments & Honors
- Academician, Chinese Academy of Sciences (2023)
- His induction chemotherapy regimens rewrote international NPC guidelines
- National Science & Technology Progress Award (2nd Prize)
Appointments
- Executive Deputy Director, Sun Yat-sen University Cancer Center
- Academician, Chinese Academy of Sciences (2023)
- Past Chair, CACA Nasopharyngeal Carcinoma Committee
Areas of Expertise
- Precision radiotherapy and comprehensive care for NPC
- Induction chemotherapy and immunotherapy strategies for NPC
- Salvage treatment for recurrent/metastatic NPC
Academic Achievements
- Elected Academician of CAS (2023)
- Induction chemotherapy regimen published in NEJM, rewriting international guidelines
- Recipient of the National Science & Technology Progress Award (2nd Prize)
Selected Publications
Gemcitabine and cisplatin induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma
New England Journal of Medicine · 2019
Corresponding author
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma
The Lancet · 2021
Corresponding author
Cancer Focus
Nasopharyngeal Cancer · Radiotherapy
Outpatient Schedule
| Tue AM · VIP Clinic |
| Fri AM · Nasopharyngeal Cancer MDT |
Schedules sync with the hospital’s official website daily at 00:00 CST. Actual availability is subject to the hospital’s same-day announcement.
Available Hospitals
Shanghai Proton and Heavy Ion Center
Shanghai · Grade III Specialty · National Particle Therapy Flagship
Xiamen Humanity Hospital (BNCT Center)
Xiamen · Grade III · China’s first AB-BNCT center
Yunnan Cancer Hospital (3rd Affiliated Hospital of Kunming Medical University)
Kunming · Grade III-A · Yunnan Provincial Cancer Center
CASE FEASIBILITY REVIEW
Submit Your Case for a Free Review
Share your contact details, confirmed diagnosis and main question. No medical files needed at this stage. A clinical coordinator will contact you within 24-48 hours.
- No medical file upload required at this stage
- By submitting you agree to our privacy policy. Your information is used solely for hospital assessment and transmitted encrypted.